Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment.

Juan XiaRui HuangYuxin ChenYong LiuJian WangXiaomin YanZhaoping ZhangChao Wu

Published in: Alimentary pharmacology & therapeutics (2020)

Serum sPD-1 and sPD-L1 levels varied among chronic HBV infected patients with different disease phases. Lower baseline sPD-1 levels were associated with HBeAg clearance after 2 years of anti-viral treatment in EPH patients.

Keyphrases

hepatitis b virus
end stage renal disease
liver failure
sars cov
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
combination therapy
drug induced
replacement therapy